ArticleJournal of pediatric gastroenterology and nutrition2025
A prediction model for genetic cholestatic disease in infancy using the machine learning approach.
Article in Journal of pediatric gastroenterology and nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A prediction model for genetic cholestatic disease in infancy using the machine learning approach.Journal of pediatric gastroenterology and nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
objectivesCholestasis in infancy poses a complex clinical conundrum for pediatric hepatologists, warranting timely diagnosis, especially for genetic diseases. This study aims to create machine learning (ML)-based prediction models, referred to as Jaundice Diagnosis Easy for Baby (JADE-B), to identify the subjects prone to genetic causes of cholestasis.
methodsWe retrieved patient data from the Integrated Medical Database at a university-affiliated tertiary medical center from 2006 to 2018. Patients with cholestatic disease were identified using liver-disease-specific International Classification of Diseases codes. A total of 47 clinical and laboratory parameters were used for ML for predicting a positive genetic disease, defined by a disease-specific genetic diagnosis matched with phenotype. Four distinct classifiers: Logistic regression, XGBoost (XGB), LightGBM (LGBM), and Random Forests were utilized to build the models.
resultsFrom a patient pool of 1845, 1008 infants below 1 year of age diagnosed with cholestatic liver disease were included in the analysis. A comprehensive set of 47 pertinent clinical and laboratory features was incorporated for training the ML models. We built five sets of models (Model 1-5), yielding an area under the receiver operating characteristic curve of 0.869, 0.884, 0.855, 0.852, and 0.836, respectively. A JADE-B model was built using 20 simple and widely accessible clinical parameters at disease onset, up to 1 month, to predict patients with genetic disorders.
conclusionsThe machine learning model prioritizes cholestatic infants for the allocation of genetic diagnostic tools and patient referrals, as well as optimizes the utilization of genetic diagnostic resources.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.